Â鶹ֱ²¥ research to develop an early diagnosis tool predicting how cancer patients will respond to chemotherapy has received a funding boost of almost half a million dollars through the Innovation Seed Fund 2023-24.<\/p>\n\n\n\n
Led by Dr Yu Yu from Curtin Medical School and the Curtin Health Innovation Research Institute, the project seeks to create a diagnostic test to identify patients who will benefit from platinum-based chemotherapy, which is commonly used in combatting advanced cancers, but often has poor outcomes.<\/p>\n\n\n\n
Dr Yu said ineffective therapy affects up to 1,500 people in WA yearly and more than two million globally.<\/p>\n\n\n\n
\u201cUnfortunately, up to half of all patients do not respond to platinum-based chemotherapy and the goal of this project is to provide clinicians with a tool that accurately predicts responses using biopsies at the onset of treatment,\u201d Dr Yu said.<\/p>\n\n\n\n
\u201cThis diagnostic test, known as ChemoDx, will enhance clinical decision-making, reduce unnecessary adverse effects and potentially improve survival rates by paving the way for tailored first-line treatments.\u201d<\/p>\n\n\n\n
Â鶹ֱ²¥ Deputy Vice-Chancellor Research Professor Melinda Fitzgerald congratulated Dr Yu and her team on the successful funding outcome.<\/p>\n\n\n\n
\u201cThis important research addresses a critical gap in cancer care and has the potential to transform cancer treatment making a real difference to people\u2019s lives,\u201d Professor Fitzgerald said.<\/p>\n\n\n\n
\u201cSupport from the Innovation Seed Fund reinforces Curtin\u2019s ongoing commitment to pioneering research that addresses critical health issues and allows our best minds to excel in their field.\u201d<\/p>\n\n\n\n
The project, titled \u201cEarly Detection of Platinum-Chemotherapy Drug Response in Solid Tumour Biopsies\u201d<\/em>, focuses initially on ovarian cancer, one of the deadliest cancers with a high incidence of drug resistance and late-stage diagnosis.<\/p>\n\n\n\n \u201cDrug resistance is a significant barrier to successful cancer treatment and the inability to predict platinum resistance exposes patients to chemotherapy side effects without therapeutic benefit and weakens the immune system,\u201d Dr Yu said.<\/p>\n\n\n\n \u201cWe have identified biomarkers that predict the response of ovarian cancer to chemotherapy and the expected outcome is the development of a diagnostic tool that will improve cancer patient treatment worldwide.\u201d<\/p>\n\n\n\n The Innovation Seed Fund, funded through the Western Australian Future Health Research and Innovation Fund, supports Western Australian innovators and early-stage start-up companies to develop and commercialise cutting-edge health and medical innovations.<\/p>\n","protected":false},"excerpt":{"rendered":" Â鶹ֱ²¥ research to develop an early diagnosis tool predicting how cancer patients will respond […]<\/p>\n","protected":false},"author":4454,"featured_media":25075,"template":"","meta":{"_acf_changed":false,"_oasis_is_in_workflow":0,"_oasis_original":0,"_oasis_task_priority":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","wds_primary_category":0,"wds_primary_research-areas":0,"footnotes":""},"categories":[115,79,43],"tags":[910,909,211],"research-areas":[],"class_list":["post-25059","media-release","type-media-release","status-publish","has-post-thumbnail","hentry","category-awards-and-achievements","category-health","category-medical-science","tag-chemotherapy","tag-innovation-seed-fund","tag-research"],"acf":{"experts":false,"post_options":{"":null,"additional_content":{"title":"","content":"","image":false},"related_courses":[{"title":"","qualification":"","link":"","description":"","faculty":""}],"credits":{"author":"","photographer":"","media":[24383,24381]},"display_author":true,"banner":{"image":false}}},"featured_image":"https:\/\/www.curtin.edu.au\/news\/wp-content\/uploads\/2024\/05\/Yu-Yu-FOR-WEB-1000x500.jpg","author_meta":{"display_name":"294101E"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/media-release\/25059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/media-release"}],"about":[{"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/types\/media-release"}],"author":[{"embeddable":true,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/users\/4454"}],"version-history":[{"count":0,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/media-release\/25059\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/media\/25075"}],"wp:attachment":[{"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/media?parent=25059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/categories?post=25059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/tags?post=25059"},{"taxonomy":"research-areas","embeddable":true,"href":"https:\/\/www.curtin.edu.au\/news\/wp-json\/wp\/v2\/research-areas?post=25059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}